Equities

Cannabis Suisse Corp

CSUI:PKC

Cannabis Suisse Corp

Actions
  • Price (USD)0.014
  • Today's Change-0.008 / -36.36%
  • Shares traded16.54k
  • 1 Year change-79.12%
  • Beta-3.6365
Data delayed at least 15 minutes, as of Jun 14 2024 16:57 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Cannabis Suisse Corp. is engaged in the business of production of over the counter (OTC) products, such as cannabidiol (CBD) oils, retail branded cigarettes and also some health-related supplements. The Company's products include Flavored Broad-Spectrum CBD Oils and CBD Isolate Tinctures with no tetrahydrocannabinol (THC). Flavored Broad-Spectrum CBD Oils products come in one fluid ounce (30 milliliters (ml)) bottles available in two flavors, such as Creme de Menthe and Cherry Vanilla. Its available CBD concentrations are 1500 milligrams (mg), 2500 mg and 3500 mg. CBD Isolate Tinctures with no THC products come in one fluid ounce (30 ml) bottles with 1000 mg CBD concentrations per bottle and 33.33 mg CBD per serving. CBD Tinctures are designed to have therapeutic effects.

  • Revenue in USD (TTM)30.00k
  • Net income in USD-254.75k
  • Incorporated2016
  • Employees--
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Himalaya Technologies Inc0.00-629.85k762.40k2.00---------0.003-0.0030.00-0.0020.00-------270.93---------------------------193.23------
Comera Life Sciences Holdings Inc1.00m-9.35m768.44k12.00------0.7681-0.4901-0.49010.05120.00330.2498--5.0883,367.50-224.98---1,094.30--73.52---900.55------0.00--97.95---237.10------
Bellerophon Therapeutics Inc5.64m-9.25m776.77k18.00--0.2086--0.1377-0.8353-0.83530.50540.30440.6414----313,333.30-105.23-55.57-165.94-77.33-----164.06------0.00-------11.69------
Evofem Biosciences Inc16.01m47.49m806.79k37.000.0014--0.01690.0504-5.92-5.920.0826-1.360.9351.722.73432,756.80295.02-211.64----63.65--315.54-1,031.550.0757-2.91----8.20--164.08---10.59--
GRI Bio Inc0.00-12.77m860.58k4.00--0.2605-----26.90-26.900.000.87530.00----0.00-382.23-192.93-869.57-353.99-------37,650.49---16.800.00-------85.61--29.46--
Neutra Corp17.40k-474.98k875.37k--------50.31-0.0002-0.00020.00001-0.00030.27860.4126-----758.75-682.94----46.15---2,723.22-2,758.850.0009-14.06-----26.09--22.28------
Yield10 Bioscience Inc300.00k-13.15m912.42k29.00------3.04-146.30-146.301.06-123.900.0627----10,344.83-274.51-91.26-2,396.54-108.09-----4,381.67-2,279.74---------86.67-35.94-6.55--1.84--
Respirerx Pharmaceuticals Inc0.00-2.17m986.63k2.00---------0.014-0.0140.00-0.04120.00----0.00-2,255.78-2,491.69---------------2.90---------12.78------
Cannabis Suisse Corp30.00k-254.75k987.43k--------32.91-0.0057-0.00570.0007-0.01030.0675-------57.35-149.71-238.71--8.37-39.11-849.17-427.20---13.573.38--28.709.00-87.10------
Kaya Holdings Inc176.06k457.55k1.02m2.000.7218--2.025.790.06370.06370.0028-0.67060.661314.24--88,030.00186.2528.68----55.6165.75281.6566.120.0161----0.00-71.36-29.62145.01-19.45----
Herborium Group, Inc.340.33k-318.65k1.09m2.00------3.21-0.3492-0.34920.3672-1.162.323.8925.94---216.97-490.56----58.3156.36-93.63-186.810.0331-39.14----19.45-18.15120.44------
Rimrock Gold Corp0.00-764.61k1.15m1.00---------0.0104-0.01040.00-0.000080.00-------187.26-236.34-1,424.92-366.85-------83,418.52---1.481.12------30.55------
Vestiage Inc0.00-21.76k1.22m0.00---------0.0004-0.00040.00-0.00110.00-------4,945.46---------------------------102.30------
Qualigen Therapeutics Inc0.00-12.48m1.26m4.00---------2.46-2.640.00-0.39230.00----0.00-118.15---364.72--21.30---------7.41--------10.22------
Data as of Jun 14 2024. Currency figures normalised to Cannabis Suisse Corp's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.